Jorg Michels

755 total citations
14 papers, 451 citations indexed

About

Jorg Michels is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jorg Michels has authored 14 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Jorg Michels's work include Cancer Treatment and Pharmacology (3 papers), Prostate Cancer Treatment and Research (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Jorg Michels is often cited by papers focused on Cancer Treatment and Pharmacology (3 papers), Prostate Cancer Treatment and Research (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Jorg Michels collaborates with scholars based in Canada, United Kingdom and United States. Jorg Michels's co-authors include Graham Packham, Peter Johnson, Christian Kollmannsberger, Nevin Murray, Fay Habens, Kim Nguyen, Eric G. Marcusson, Ruth W. Craig, Jason O’Neill and Kam Y. J. Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Oncogene.

In The Last Decade

Jorg Michels

13 papers receiving 446 citations

Peers

Jorg Michels

ONCOL

PRM

IMMUN

Milena Vuica‐Ross United States

Gerd Leder Germany

Justin Cidado United States

Alexander Hoellein Germany

Huihong You United States

Kishore Shakalya United States

Carolina Castilla Spain

Bei Jin China

Raymond J. Lim United States

Milena Vuica‐Ross United States

Jorg Michels

465 ×1.7

130 ×0.9

ONCOL

68 ×0.7

PRM

93 ×1.1

IMMUN

74 ×1.0

Citations per year, relative to Jorg Michels Jorg Michels (= 1×) peers Milena Vuica‐Ross

Countries citing papers authored by Jorg Michels

Since Specialization

Citations

This map shows the geographic impact of Jorg Michels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorg Michels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorg Michels more than expected).

Fields of papers citing papers by Jorg Michels

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorg Michels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorg Michels. The network helps show where Jorg Michels may publish in the future.

Co-authorship network of co-authors of Jorg Michels

This figure shows the co-authorship network connecting the top 25 collaborators of Jorg Michels. A scholar is included among the top collaborators of Jorg Michels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorg Michels. Jorg Michels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Michels, Jorg, et al.. (2013). Metastatic signet-ring cell cancer of the bladder responding to chemotherapy with capecitabine: case report and review of literature. Canadian Urological Association Journal. 4(2). 55–55. 9 indexed citations

Michels, Jorg, et al.. (2011). Synchronous metastatic seminoma and primary retroperitoneal ganglioneuroma; a case report and literature review. Canadian Urological Association Journal. 5(6). e109–e112. 1 indexed citations

Hirte, Hal W., W. P. McGuire, Robert P. Edwards, et al.. (2010). Final results of a phase II study of voreloxin in women with platinum-resistant ovarian cancer.. Journal of Clinical Oncology. 28(15_suppl). 5002–5002. 4 indexed citations

Michels, Jorg, Susan Ellard, Lyly Le, et al.. (2009). A phase IB study of ABT-751 in combination with docetaxel in patients with advanced castration-resistant prostate cancer. Annals of Oncology. 21(2). 305–311. 18 indexed citations

Hirte, Hal W., W. P. McGuire, Robert P. Edwards, et al.. (2009). A phase II trial of voreloxin in women with platinum-resistant ovarian cancer. Journal of Clinical Oncology. 27(15_suppl). 5559–5559. 4 indexed citations

McGuire, W. P., Hal W. Hirte, Ursula A. Matulonis, et al.. (2008). A phase II trial of SNS-595 in women with platinum resistant epithelial ovarian cancer. Journal of Clinical Oncology. 26(15_suppl). 5582–5582.

Michels, Jorg, et al.. (2007). Intrinsic resistance of prostate cancer to the BH3 mimetic ABT-737 is related to expression of the anti-apoptotic Mcl-1 and additional survival and apoptosis regulating pathways. Molecular Cancer Therapeutics. 6. 1 indexed citations

Michels, Jorg, et al.. (2006). Immunohistochemical analysis of the antiapoptotic Mcl‐1 and Bcl‐2 proteins in follicular lymphoma. British Journal of Haematology. 132(6). 743–746. 17 indexed citations

Habens, Fay, Becky M. Pickering, Jorg Michels, et al.. (2006). Distinct promoters mediate constitutive and inducible Bcl-XL expression in malignant lymphocytes. Oncogene. 26(13). 1910–1919. 12 indexed citations

10.

Michels, Jorg, et al.. (2006). First‐ and second‐line chemotherapy with docetaxel or mitoxantrone in patients with hormone‐refractory prostate cancer. Cancer. 106(5). 1041–1046. 64 indexed citations

11.

Michels, Jorg, et al.. (2006). The Combination of Raltitrexed (Tomudex) and Mitomycin-C in the Treatment of Advanced Colorectal Cancer — A Phase II Study. Clinical Oncology. 18(6). 431–435. 1 indexed citations

12.

Michels, Jorg, et al.. (2005). First- and second-line chemotherapy with docetaxel or mitoxantrone in patients with hormone-refractory prostate cancer (HRPC): Does sequence matter?. Journal of Clinical Oncology. 23(16_suppl). 4611–4611. 14 indexed citations

13.

Michels, Jorg, Peter Johnson, & Graham Packham. (2004). Mcl-1. The International Journal of Biochemistry & Cell Biology. 37(2). 267–271. 184 indexed citations

14.

Michels, Jorg, Jason O’Neill, Fay Habens, et al.. (2004). Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavage. Oncogene. 23(28). 4818–4827. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact